Tulsi Consumption and Its Effects on Cognition, Stress and Anxiety

NCT03184909 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-09-17

No results posted yet for this study

Summary

Tulsi and its effects on facilitative cognitive enhancement through lowering levels of stress and anxiety. A randomised placebo-controlled clinical trial.

Conditions

  • Cognitive Change

Interventions

DRUG

Ocimum Sanctum

Active capsules containing leaves of organically prepared ocimum sanctum

DRUG

Placebo

Placebo capsules of look alike inert substance for control

Sponsors & Collaborators

  • Composite Interceptive Med Science

    lead INDUSTRY

Principal Investigators

  • Alben Sigamani, MD · Narayana Hrudayalaya Limited

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-14
Primary Completion
2018-03-30
Completion
2018-03-31

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03184909 on ClinicalTrials.gov